We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$541B
AUM Growth
+$82.1B
Cap. Flow
+$80.6B
Cap. Flow %
14.9%
Top 10 Hldgs %
15.6%
Holding
10,816
New
1,380
Increased
6,046
Reduced
2,042
Closed
943

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 9.06%
3 Consumer Discretionary 7.01%
4 Healthcare 6.25%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIMAW
9576
SIM Acquisition Corp I Warrant
SIMAW
$125 ﹤0.01%
1,250
SABSW icon
9577
SAB Biotherapeutics Warrant
SABSW
$186K
$122 ﹤0.01%
+1,633
New +$98
LSEAW
9578
DELISTED
Landsea Homes Corporation Warrant
LSEAW
$120 ﹤0.01%
+1,176
New +$239
ASTI icon
9579
Ascent Solar Technologies
ASTI
$28.6M
$118 ﹤0.01%
36
-1,070
-97% -$2.93K
GROV icon
9580
Grove Collaborative
GROV
$46.2M
$118 ﹤0.01%
85
-359
-81% -$494
NIVFW
9581
NewGenIvf Group Warrants
NIVFW
$118 ﹤0.01%
2,623
-1,069
-29% -$33
PAUG icon
9582
Innovator US Equity Power Buffer ETF August
PAUG
$861M
$116 ﹤0.01%
3
-1,854
-100% -$71.1K
PROC
9583
DELISTED
Procaps Group, S.A. Ordinary Shares
PROC
$115 ﹤0.01%
+49
New +$91
RFAC
9584
DELISTED
RF Acquisition Corp. Class A Common Stock
RFAC
$114 ﹤0.01%
10
IONR
9585
Ioneer
IONR
$268M
$112 ﹤0.01%
28
-1,355
-98% -$7.77K
TLSI icon
9586
TriSalus Life Sciences
TLSI
$279M
$110 ﹤0.01%
22
GBBK
9587
DELISTED
Global Blockchain Acquisition Corp. Common Stock
GBBK
$110 ﹤0.01%
10
PROCW
9588
DELISTED
Procaps Group, S.A. Warrants
PROCW
$110 ﹤0.01%
2,615
-4,067
-61% -$102
YOTAW
9589
DELISTED
Yotta Acquisition Corporation Warrant
YOTAW
$109 ﹤0.01%
2,720
-9,880
-78% -$479
MSAIW icon
9590
MultiSensor AI Holdings Warrant
MSAIW
$107 ﹤0.01%
+2,676
New +$91
NETDU
9591
DELISTED
Nabors Energy Transition Corp II Unit
NETDU
$107 ﹤0.01%
+10
New +$108
RNWWW
9592
ReNew Energy Global PLC Warrant
RNWWW
$61.1K
$106 ﹤0.01%
652
WINVW
9593
DELISTED
WinVest Acquisition Corp. Warrant
WINVW
$104 ﹤0.01%
+7,400
New +$117
PIII icon
9594
P3 Health Partners
PIII
$32.7M
$103 ﹤0.01%
9
+4
+80% +$59
GDSTW
9595
DELISTED
Goldenstone Acquisition Limited Warrants
GDSTW
$103 ﹤0.01%
6,842
-2,048
-23% -$60
FMST
9596
Foremost Lithium Resource & Technology
FMST
$22.8M
$102 ﹤0.01%
+74
New +$148
PHAR
9597
Pharming Group
PHAR
$713M
$101 ﹤0.01%
+10
New +$85
MACIU
9598
Melar Acquisition Corp I Unit
MACIU
$101 ﹤0.01%
+10
New +$102
SJLD
9599
SanJac Alpha Low Duration ETF
SJLD
$2.52M
$100 ﹤0.01%
+4
New +$100
NXTS
9600
Nexentis Technologies
NXTS
$2.49M
$99 ﹤0.01%
2
-485
-100% -$27K

Similar funds

UBS Group's Q4 2024 Portfolio in Review

As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,380 new positions and adding to 6,046 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.

  • UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
  • UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
  • UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
  • UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
  • UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
  • UBS Group opened 1,380 new positions and closed 943 in Q4 2024.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.